Answers are grounded in this paper and cite their sources.
As RANTES is discussed in the literature as a possible contributor to inflammatory diseases, and though it might have oncogenic effects, we hypothesize that FDOJ in areas of improper and incomplete wound healing in the jawbone might act as hyperactivated signaling pathways, while serving as an unknown source of "silent inflammation". Because of the wide range of RANTES in immune diseases, treating FDOJ can cover many potential prediction or prognosis of individual outcomes.
No takes yet. Share an insight, caveat, or question.
Lechner et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: